How pills undermine skills: Moralization of cognitive enhancement and causal selection.

Bioethics Causation Cognitive enhancement Moral foundations

Journal

Consciousness and cognition
ISSN: 1090-2376
Titre abrégé: Conscious Cogn
Pays: United States
ID NLM: 9303140

Informations de publication

Date de publication:
05 2021
Historique:
received: 10 01 2020
revised: 04 03 2021
accepted: 15 03 2021
pubmed: 29 3 2021
medline: 25 11 2021
entrez: 28 3 2021
Statut: ppublish

Résumé

Despite the promise to boost human potential and wellbeing, enhancement drugs face recurring ethical scrutiny. The present studies examined attitudes toward cognitive enhancement in order to learn more about these ethical concerns, who has them, and the circumstances in which they arise. Fairness-based concerns underlay opposition to competitive use-even though enhancement drugs were described as legal, accessible and affordable. Moral values also influenced how subsequent rewards were causally explained: Opposition to competitive use reduced the causal contribution of the enhanced winner's skill, particularly among fairness-minded individuals. In a follow-up study, we asked: Would the normalization of enhancement practices alleviate concerns about their unfairness? Indeed, proliferation of competitive cognitive enhancement eradicated fairness-based concerns, and boosted the perceived causal role of the winner's skill. In contrast, purity-based concerns emerged in both recreational and competitive contexts, and were not assuaged by normalization.

Identifiants

pubmed: 33774366
pii: S1053-8100(21)00046-5
doi: 10.1016/j.concog.2021.103120
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

103120

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Emilian Mihailov (E)

University of Bucharest, Romania.

Blanca Rodríguez López (B)

Complutense University of Madrid, Spain.

Florian Cova (F)

University of Geneva, Switzerland.

Ivar R Hannikainen (IR)

University of Granada, Spain. Electronic address: ivar@ugr.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH